Ingalls & Snyder LLC Zoetis Inc. Transaction History

Ingalls & Snyder LLC

$2.56 Billion
Q3 2024

A detailed history of Ingalls & Snyder LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Ingalls & Snyder LLC holds 13,299 shares of ZTS stock, worth $2.34 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

13,299

Previous 13,105 1.48%

Holding current value

$2.34 Million

Previous $2.27 Million 14.35%

% of portfolio

0.1%

Previous 0.1%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$172.58 - $196.48 $33,480 - $38,117	194 Added 1.48%	13,299 $2.6 Million
Q2 2024 Jul 31, 2024	SELL	$145.54 - $178.83 $107,699 - $132,334	-740 Reduced 5.34%	13,105 $2.27 Million
Q1 2024 May 13, 2024	BUY	$165.67 - $199.94 $17,892 - $21,593	108 Added 0.79%	13,845 $2.34 Million
Q4 2023 Jan 29, 2024	SELL	$151.44 - $200.09 $77,840 - $102,846	-514 Reduced 3.61%	13,737 $2.71 Million
Q3 2023 Nov 02, 2023	SELL	$167.14 - $192.77 $53,484 - $61,686	-320 Reduced 2.2%	14,251 $2.48 Million
Q2 2023 Jul 27, 2023	BUY	$160.94 - $186.23 $160 - $186	1 Added 0.01%	14,571 $2.51 Million
Q1 2023 May 09, 2023	SELL	$145.48 - $175.02 $17,603 - $21,177	-121 Reduced 0.82%	14,570 $2.43 Million
Q4 2022 Jan 31, 2023	SELL	$131.14 - $157.47 $24,392 - $29,289	-186 Reduced 1.25%	14,691 $2.15 Million
Q3 2022 Oct 21, 2022	SELL	$148.29 - $182.55 $46,711 - $57,503	-315 Reduced 2.07%	14,877 $2.21 Million
Q2 2022 Aug 11, 2022	SELL	$155.97 - $200.09 $8,266 - $10,604	-53 Reduced 0.35%	15,192 $2.61 Million
Q1 2022 May 09, 2022	SELL	$181.39 - $234.03 $906 - $1,170	-5 Reduced 0.03%	15,245 $2.88 Million
Q4 2021 Feb 11, 2022	BUY	$193.69 - $247.03 $9,684 - $12,351	50 Added 0.33%	15,250 $3.72 Million
Q3 2021 Oct 27, 2021	BUY	$189.29 - $209.69 $9,275 - $10,274	49 Added 0.32%	15,200 $2.95 Million
Q2 2021 Aug 03, 2021	SELL	$155.9 - $187.99 $88,863 - $107,154	-570 Reduced 3.63%	15,151 $2.82 Million
Q1 2021 Apr 21, 2021	SELL	$144.0 - $169.39 $72,288 - $85,033	-502 Reduced 3.09%	15,721 $2.48 Million
Q4 2020 Jan 27, 2021	BUY	$157.07 - $174.35 $12,094 - $13,424	77 Added 0.48%	16,223 $2.69 Million
Q3 2020 Oct 21, 2020	BUY	$137.1 - $165.37 $5,484 - $6,614	40 Added 0.25%	16,146 $2.67 Million
Q2 2020 Jul 31, 2020	BUY	$111.92 - $142.53 $7,722 - $9,834	69 Added 0.43%	16,106 $2.21 Million
Q1 2020 Apr 22, 2020	BUY	$92.66 - $144.94 $59,951 - $93,776	647 Added 4.2%	16,037 $1.89 Million
Q4 2019 Jan 15, 2020	BUY	$116.25 - $133.25 $360,491 - $413,208	3,101 Added 25.23%	15,390 $2.04 Million
Q4 2018 Jan 24, 2019	SELL	$79.28 - $95.27 $7,928 - $9,527	-100 Reduced 0.81%	12,289 $1.05 Million
Q3 2018 Oct 24, 2018	SELL	$83.5 - $93.23 $16,700 - $18,646	-200 Reduced 1.59%	12,389 $1.13 Million
Q2 2018 Aug 10, 2018	SELL	$79.9 - $89.2 $799 - $892	-10 Reduced 0.08%	12,589 $1.07 Million
Q3 2017 Oct 20, 2017	BUY	$59.73 - $65.4 $752,538 - $823,974	12,599	12,599 $803,000

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account

Ingalls & Snyder LLC Zoetis Inc. Transaction History